Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matija Hedl

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2020
Myeloid Cell-Intrinsic IRF5 Promotes T Cell Responses through Multiple Distinct Checkpoints In Vivo, and <i>IRF5</i> Immune-Mediated Disease Risk Variants Modulate These Myeloid Cell FunctionsJie Yan, Matija Hedl, Clara Abraham
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2020
Disease Risk-Associated Genetic Variants in <i>STAT1</i> and <i>STAT4</i> Function in a Complementary Manner to Increase Pattern-Recognition Receptor-Induced Outcomes in Human MacrophagesMatija Hedl, Rui Sun, Clara Abraham
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2021
The E3 ubiquitin ligase RNF186 and <i>RNF186</i> risk variants regulate innate receptor-induced outcomesKishu Ranjan, Matija Hedl, Clara Abraham
Gut|May 18, 2019
IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomesRui Sun, Matija Hedl, Clara Abraham
Journal of Immunology (Baltimore, Md. : 1950)|May 29, 2015
Twist1 and Twist2 Contribute to Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages through the Coordinated Regulation of Transcriptional Repressors and ActivatorsShasha Zheng, Matija Hedl, Clara Abraham
Cell Reports|August 23, 2016
IRF5 and IRF5 Disease-Risk Variants Increase Glycolysis and Human M1 Macrophage Polarization by Regulating Proximal Signaling and Akt2 ActivationMatija Hedl, Jie Yan, Clara Abraham
The Journal of Clinical Investigation|April 25, 2017
An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomesJie Yan, Matija Hedl, Clara Abraham
Cellular and Molecular Gastroenterology and Hepatology|August 23, 2020
TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk VariantsRui Sun, Matija Hedl, Clara Abraham
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2015
MTMR3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activationAmit Lahiri, Matija Hedl, Clara Abraham
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2015
TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophagesShasha Zheng, Matija Hedl, Clara Abraham
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2020
Myeloid Cell-Intrinsic IRF5 Promotes T Cell Responses through Multiple Distinct Checkpoints In Vivo, and <i>IRF5</i> Immune-Mediated Disease Risk Variants Modulate These Myeloid Cell FunctionsJie Yan, Matija Hedl, Clara Abraham
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2020
Disease Risk-Associated Genetic Variants in <i>STAT1</i> and <i>STAT4</i> Function in a Complementary Manner to Increase Pattern-Recognition Receptor-Induced Outcomes in Human MacrophagesMatija Hedl, Rui Sun, Clara Abraham
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2021
The E3 ubiquitin ligase RNF186 and <i>RNF186</i> risk variants regulate innate receptor-induced outcomesKishu Ranjan, Matija Hedl, Clara Abraham
Gut|May 18, 2019
IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomesRui Sun, Matija Hedl, Clara Abraham
Journal of Immunology (Baltimore, Md. : 1950)|May 29, 2015
Twist1 and Twist2 Contribute to Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages through the Coordinated Regulation of Transcriptional Repressors and ActivatorsShasha Zheng, Matija Hedl, Clara Abraham
Cell Reports|August 23, 2016
IRF5 and IRF5 Disease-Risk Variants Increase Glycolysis and Human M1 Macrophage Polarization by Regulating Proximal Signaling and Akt2 ActivationMatija Hedl, Jie Yan, Clara Abraham
The Journal of Clinical Investigation|April 25, 2017
An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomesJie Yan, Matija Hedl, Clara Abraham
Cellular and Molecular Gastroenterology and Hepatology|August 23, 2020
TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk VariantsRui Sun, Matija Hedl, Clara Abraham
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2015
MTMR3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activationAmit Lahiri, Matija Hedl, Clara Abraham
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2015
TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophagesShasha Zheng, Matija Hedl, Clara Abraham
Pageof 4